Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Molecular & Cellular Oncology|April 13, 2017
p53 gain-of-function mutations promote metastasis via ENTPD5 upregulation and enhanced N-glycoprotein foldingOleg Timofeev, Thorsten Stiewe
Cell Cycle (Georgetown, Tex.)|November 22, 2019
Inactivation of Mdm2 restores apoptosis proficiency of cooperativity mutant p53 in vivoBoris Klimovich, Thorsten Stiewe, Oleg Timofeev
Trends in Pharmacological Sciences|May 11, 2024
Enhancing oncogenic signaling to kill cancer cellsMaxim Noeparast, Oleg Timofeev, Martin Pichler
Cell Cycle (Georgetown, Tex.)|December 22, 2004
A subtle change in p38 MAPK activity is sufficient to suppress in vivo tumorigenesisOleg Timofeev, Ting Yi Lee, Dmitry V Bulavin
FEBS Letters|February 5, 2009
Human Cdc25A phosphatase has a non-redundant function in G2 phase by activating Cyclin A-dependent kinasesOleg Timofeev, Onur Cizmecioglu, Entan Hu, et al.
Nature Protocols|February 3, 2026
Secreted luciferases as a minimally invasive 3R-compliant tool for accurate monitoring of tumor burdenNastasja Merle, Imke Bullwinkel, Oleg Timofeev, et al.
NPJ Precision Oncology|March 15, 2024
ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery frameworkOleg Timofeev, Philippe Giron, Steffen Lawo, et al.
The Journal of Biological Chemistry|April 3, 2010
Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transitionOleg Timofeev, Onur Cizmecioglu, Florian Settele, et al.
Experimental Neurology|August 18, 2010
Increased subventricular zone-derived cortical neurogenesis after ischemic lesionMaria Kreuzberg, Evgeny Kanov, Oleg Timofeev, et al.
Pageof 3